Mercury Biomed Awarded $1.5M Phase II NIH Grant

Mercury Biomed Awarded $1.5M Phase II NIH Grant

CLEVELAND – – (9/19/2018) – Mercury Biomed, a company developing a novel approach to managing core body temperature, was awarded a $1.5 million non-dilutive Phase II Small Business Technology Transfer (STTR) grant through the National Institute of General Medical Sciences…

Read more